Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2022 - 12 - 15
点击次数: 0
Positions: 首席执行官,执行董事
Company: 基石药业
个人简介:
杨建新  医学博士, 分子遗传学博士 基石药业 首席执行官,执行董事 ▪ 国家特聘专家,北京市特聘专家,江苏省双创人才,国家科技部重大专项评审专家, 国家药监局 ICH-E8 指导原则咨询专家,CSCO 临床研究专委会委员,中国抗癌协 会 ACTS 委员,中国医药创新促进会医药数字化及创新疗法专委会委员; ▪ 临床医学专家、科学家,拥有海外大型跨国药企、科研院所等机构逾 25 年的学术 科研及生物制药研发的资深经验,涵盖从药物发现, 转化医学到临床开发阶段。发 表文章/会议报告 50 余篇,拥有专利 9 项; ▪ 现任基石药业首席执行官以及执行董事,全面负责基石各项业务发展以及策略制定; 六年时间里带领基石药业成功上市四款创新药,分别为泰吉华®(阿伐替尼),普 吉华®(普拉替尼),择捷美®(舒格利单抗),拓舒沃®(艾伏尼布); ▪ 曾任百济神州高级副总裁及临床开发负责人;组建百济神州临床团队,并领导 4 个 肿瘤药物从一期到关键试验阶段的临床开发工作,包括已获批上市的中国首个自主 研发的抗 PD-1 替雷利珠单抗,BTK 抑制剂泽布替尼和 PARP 抑制剂帕米帕利;▪ 曾任美国科文斯肿瘤医学总监;曾任辉瑞肿瘤生物标记物资深首席科学家;曾任 Tularik/Amgen 公司研究科学家; 领导超过十个肿瘤项目的研究与开发; ▪ 拥有美国德州西南医学院博士学位,师从诺贝尔奖获得者 Mike Brown 博士和 Joseph Goldstein 博士;哈佛大学博士后,师从 Stuart Schreiber 博士;此前在南 京医科大学和湖北医学院咸宁分院取得医学学位。
发布时间: 2022 - 12 - 15
点击次数: 0
Positions: BD VP
Company: Jiangsu Simcere Pharmaceutical Group
个人简介:
陈晨 (Michael) 博士,现担任江苏先声药业副总裁,主要负责领导公司业务发展和联盟管理中国团队的工作。在加入先声之前,陈博士曾担任中山康方BD副总裁,和德国默克公司医药研发外部创新亚太区负责。在默克工作期间,陈博士是默克亚洲和中国研发中心的领导成员之一,针对自身研发管线,协助团队开展亚太地区的协同工作,并管理亚太地区以建立起来的研发创新外部合作。归国前,陈博士先后在英国埃塞克斯大学获得细胞和分子生物学学士学位、英国诺丁汉大学获得癌症免疫治疗硕士学位、英国伦敦帝国理工大学获得生物化学博士学位。在加入默克之前,他曾在伦敦大学学院从事博士后研究,之后在英国生物技术公司 Spirogen(后被阿斯利康集团旗下全球生物制药分公司 MedImmune 收购) 领导研究项目,归国后加入药明生物和睿智化学开展商务拓展及投资工作。
发布时间: 2022 - 12 - 15
点击次数: 0
Positions: CBO
Company: Alphamab Oncology
个人简介:
韩净先生目前供职于康宁杰瑞担任首席商务官职位,主要负责公司商业化运营,上市前临床协调部工作以及外包产品(石药先声)商业化合作。在此之前,韩净先生担任嘉和生物高级副总裁职位,负责组建营销团队及上市前各项商业化工作。在担任上海君实生物副总经理期间,建立营销部搭建团队至550人,制定以大医学概念为前提的市场销售策略,2018年在比竞争对手少一半人员的情况下完成7.74亿销售(10个月),费用比仅48%(信达76%,百济2020年上市第一年90%以上);开展肺肝食管淋巴瘤等癌肿ISS项目80余项,部分如肝内胆管癌(PD-1+仑伐+Gemox,40%,上海中山医院樊嘉周俭)ORR达90%,后正式立项三期三臂临床,二期数据列入2021年CSCO胆管癌治疗指南。作为临床医生出生的韩净先生也曾在罗氏制药、拜耳医药、 阿斯利康、勃林格殷格翰、默沙东等大型跨国药企均有过从业经验。
发布时间: 2022 - 12 - 15
点击次数: 0
Positions: Consulting Services Leader
Company: Clarivate Analytics
个人简介:
Dr. Xue Jiang is the Consulting Service Leader (including Life Sciences and Healthcare) of Greater China at Clarivate Consulting.He has 13+ years of industry experience in the life sciences and healthcare sector, including more than 10 years of experience in management consulting and industry analysis, and 2 years in industrial R&D and technology transfer.Prior to joining Clarivate, Dr. Jiang worked at WuXi AppTec headquarters in Shanghai, where he was responsible for building differentiated industry analysis and consulting capabilities. He has also worked for Euromonitor International in North America, where he has provided management consulting and industry research services to Fortune 500 companies, leading startups, government agencies and investment firms, and has been interviewed by media outlets such as the Associated Press, Financial Post and CTV News to share industry insight and perspectives. He holds a Ph.D. in biomedical engineering from Rutgers University (a joint program with UMDNJ, University of Medical & Dental of New Jersey), a bachelor's degree from Shanghai Jiao Tong University (Top5%), and several utility patents. He is also committed to public welfare and philanthropic causes such as poverty eradication, promotion of science & technology, and the fight against disease.